Two centres for infectious diseases establishedFebruary 05, 2004The Netherlands Organisation for Scientific Research (NWO) has awarded a so-called centre subsidy to two research centres which are currently being established. Each centre will receive a total of 1.35 million euros. These funds must be used by the centres over the next five years to carry out multidisciplinary research towards the prevention, management or treatment of infectious diseases in the Netherlands or in developing countries. The focus is on flu, AIDS, malaria and tuberculosis. Flu vaccine Under the leadership of Prof. J.C. (]an) Wilschut, Departments of Medical Microbiology and Molecular Virology, University of Groningen In this centre, named NIVAREC (Netherlands Influenza Vaccine Research Centre), researchers from the University of Groningen and the Erasmus MC Rotterdam will work together with researchers from Solvay Pharmaceuticals in Weesp. The centre wants to develop and produce new flu vaccines to ensure that the Netherlands is optimally prepared for a flu pandemic. AIDS, malaria and tuberculosis Under the leadership of Prof. J.W.M. (Jos) van der Meer, Department of General Internal Medicine, Nijmegen University Medical Centre This centre, named PRIOR (Poverty Relationship Infection Oriented Research), forms a unique cooperation for the control of poverty-related infectious diseases in the third world. Researchers from Nijmegen University Medical Centre, Leiden University Medical Center, Universiteit Maastricht, Wageningen University and Research Centre and the National Institute of Public Health and the Environment (RIVM) will work together with colleagues in Tanzania and Indonesia. The aim is to develop a knowledge infrastructure in third world countries for poverty-related infectious diseases. The subsidy for research centres is one of the initiatives from ZonMw (Netherlands Organisation for Health Research and Development) and NWO to stimulate research into infectious diseases. In 2002 TOPIZ, (Platform for the future research of infectious diseases), was set up. TOPIZ draws attention to the importance of the knowledge infrastructure for infectious diseases as part of the preparation for future problems. Since 2001, ZonMw and NWO have been involved in the establishment of EDCTP, the European and Developing Countries Clinical Trials Partnership. EDCTP facilitates clinical research in developing countries into HIV/AIDS, malaria and tuberculosis. The subsidy for research centres is a joint initiative from NWO, NWO-WOTRO (Netherlands Foundation for the Advancement of Tropical Research) and ZonMw. The centres must strengthen the cooperation between subject areas such as cell biology, immunology, epidemiology and social scientific research. The centres are virtual, in other words research groups from different institutes participate in the centres. NWO (Netherlands Organization for Scientific Research) |
|||||||||||||||||||||
| Related Infectious Diseases Current Events and Infectious Diseases News Articles New study finds MRSA on the rise in hospital outpatients The community-associated strain of the deadly superbug MRSA-an infection-causing bacteria resistant to most common antibiotics-poses a far greater health threat than previously known and is making its way into hospitals, according to a study in the December issue of Emerging Infectious Diseases. Barn Personnel Experience Higher-Than Average Rates of Respiratory Symptoms The estimated 4.6 million Americans involved in the equine industry may be at risk of developing respiratory symptoms due to poor air quality in horse barns. Preventing H1N1 spread to health care workers: Dilemma, debate and confusion A commentary in the December issue of The Lancet Infectious Diseases brings to light the gaps in knowledge on the transmission of a common pathogen - the influenza virus - and its impact on decisions about how best to protect health care workers. New findings suggest strategy to help generate HIV-neutralizing antibodies New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The Protein Srebp2 Drives Cholesterol Formation in Prion-Infected Neuronal Cells Which May Promote Prion-Dependent Diseases The regulating protein Srebp2 drives cholesterol formation, which prions need for their propagation, in prion-infected neuronal cells. Texas A&M Researchers Examine How Viruses Destroy Bacteria Viruses are well known for attacking humans and animals, but some viruses instead attack bacteria. Texas A&M University researchers are exploring how hungry viruses, armed with transformer-like weapons, attack bacteria, which may aid in the treatment of bacterial infections. Pivotal study for PSD502 -- the first potential treatment for premature ejaculation At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora" - AIM:PLE)., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE). Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease. Small nanoparticles bring big improvement to medical imaging If you're watching the complex processes in a living cell, it is easy to miss something important-especially if you are watching changes that take a long time to unfold and require high-spatial-resolution imaging. New explanation for nature's hardiest life form Got food poisoning? The cause might be bacterial spores, en extremely hardy survival form of bacteria, a nightmare for health care and the food industry and an enigma for scientists. More Infectious Diseases Current Events and Infectious Diseases News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||